4.7 Review

Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy

Journal

CANCER LETTERS
Volume 373, Issue 1, Pages 19-26

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2016.01.022

Keywords

Atg4 protease; Autophagy; Atg8/LC3; Apoptosis; Targeted cancer therapy

Categories

Funding

  1. National 973 Basic Research Program of China [2013CB911300]
  2. National Natural Science Foundation of China [81402496, 81473091]

Ask authors/readers for more resources

Atg4 proteases are cysteine proteases, which are well known for their crucial roles in the lipidation and delipidation of LC3 during the autophagy process. At least four human Atg4 homologs have been reported according to their sequence homology to the yeast Saccharomyces cerevisiae (Sc) Atg4. Accumulating evidence has recently indicated that abnormal expression levels of some human Atg4 proteins occur in several types of cancer cells, which may be closely related to tumor progression, tumor suppression and cancer therapy resistance. In this review, we focus on highlighting the pivotal roles of the human Atg4 proteases in the LC3 conjugation system and their major function in autophagy. Moreover, we further explore the roles of human Atg4 proteases as potential novel targets for cancer therapy. Taken together, these findings would shed light on elucidating the key roles of Atg4 proteases from autophagy modulation to targeted cancer therapy. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available